Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 23 Enz. Inhib. hit(s) with all data for entry = 50044799
TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030792(CHEMBL3342401)
Affinity DataIC50:  77nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030795(CHEMBL3342398)
Affinity DataIC50:  120nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030794(CHEMBL3342399)
Affinity DataIC50:  160nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030793(CHEMBL3342400)
Affinity DataIC50:  190nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030798(CHEMBL3342395)
Affinity DataIC50:  220nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030797(CHEMBL3342396)
Affinity DataIC50:  750nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030813(CHEMBL3355142)
Affinity DataIC50:  1.30E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030796(CHEMBL3342397)
Affinity DataIC50:  1.80E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030800(CHEMBL3342393)
Affinity DataIC50:  1.90E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedPDB3D3D Structure (crystal)

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030791(CHEMBL3342402)
Affinity DataIC50:  3.00E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedPDB3D3D Structure (crystal)

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030801(CHEMBL3342392)
Affinity DataIC50:  3.50E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030799(CHEMBL3342394)
Affinity DataIC50:  3.60E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030804(CHEMBL3342389)
Affinity DataIC50:  5.50E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030805(CHEMBL3342388)
Affinity DataIC50:  8.10E+3nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030812(CHEMBL3342381)
Affinity DataIC50:  1.80E+4nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030807(CHEMBL3342386)
Affinity DataIC50:  2.40E+4nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030806(CHEMBL3342387)
Affinity DataIC50:  5.60E+4nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030808(CHEMBL3342385)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030809(CHEMBL3342384)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030810(CHEMBL3342383)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030811(CHEMBL3342382)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030802(CHEMBL3342391)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed

TargetIndoleamine 2,3-dioxygenase 1(Human)
Dainippon Sumitomo Pharma

Curated by ChEMBL
LigandPNGBDBM50030803(CHEMBL3342390)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human IDO1 assessed as reduction in convertion of N-formylkynurenine to kynurenine incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed